Trial Details

Recruiting
Basic Information
Clinical ID c2304
Identifier RBR-955md27
Trial Title Use of Modulen in patients with Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions Crohn's disease; Ulcerative colitis
Interventions Nutritional supplementation with Modulen, standard formula enriched with transforming growth factor beta. Case series of thirty patients with Crohns Disease or Ulcerative Colitis. Patients will be supplemented with Modulen throughout the study period to be used at the standard dosage of five hundred ml of reconstituted supplement daily. The supplement will be provided free of charge by Nestle. Patients will be monitored by the team and will be evaluated in three stages, described as before supplementation with Modulen, thirty days after starting Modulen supplementation, sixty days after starting Modulen supplementation. At each moment, clinical data will be collected, evaluation of the clinical activity of the disease, biochemical evaluation, nutritional evaluation and evaluation of psychological outcomes (assessment form).;G07.203.300.456
Participant Information
Sponsor Faculdade de Medicina de Botucatu
City -
Country/Region Brazil
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement INFANT
Study Design
Study Type Intervention
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2023-12-01